Both canonical and noncanonical NF-κB activation through different mechanisms has been reported in several types of human hematological malignancies, chiefly lymphoid leukemia and lymphoma (reviewed by Jost and Ruland [27] and Packham [28]). Here, NFKB1 is linked to hematologic disorder.